Literature DB >> 16797080

Antidepressant withdrawal symptoms-telephone calls to a national medication helpline.

David Taylor1, Suzanne Stewart, Anne Connolly.   

Abstract

AIMS AND
METHOD: Withdrawal symptoms are associated with cessation of all antidepressants but particularly paroxetine and venlafaxine. We aimed to examine rates of withdrawal symptoms reported to a national medication helpline over seven and a half year period. All calls reporting symptoms of antidepressant withdrawal were noted from a retrospective examination of contemporaneous handwritten records.
RESULTS: Between October 1997 and March 2005, the national medication helpline received 22,422 calls of which 1753 (7.8%) concerned antidepressant discontinuation symptoms. Of these, 690 calls (39.36%) related to paroxetine and 252 (14.38%) to venlafaxine. Calls regarding paroxetine increased ten-fold in the month following a BBC 'Panorama' programme centring on problems associated with its use. Comparing number of calls with the number of prescriptions written over the same period revealed that MAOIs have the highest rate of reported reactions. CLINICAL IMPLICATIONS: Withdrawal symptoms were reported with nearly all antidepressants but most commonly with paroxetine and venlafaxine. Television programmes reporting adverse consequences of drug therapy can greatly increase reporting of discontinuation reactions. The highest rate of reporting adverse discontinuation symptoms was for MAOIs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16797080     DOI: 10.1016/j.jad.2006.04.026

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  9 in total

1.  Uncontrolled self-medication with venlafaxine in a patient with major depressive disorder.

Authors:  Ji-Hye Song; Bum-Hee Yu; Dongsoo Lee; Se Chang Yoon; Hong Jin Jeon
Journal:  Psychiatry Investig       Date:  2010-12-31       Impact factor: 2.505

2.  Pharmacotherapy of mood disorders and treatment discontinuation.

Authors:  Malcolm Lader
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example.

Authors:  Florence van Hunsel; Anneke Passier; Kees van Grootheest
Journal:  Br J Clin Pharmacol       Date:  2009-02-26       Impact factor: 4.335

Review 4.  Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression.

Authors:  Brian Leonard; David Taylor
Journal:  J Psychopharmacol       Date:  2010-02-10       Impact factor: 4.153

5.  An adverse drug reaction clinic: Breathing fresh life into the pharmacovigilance programme.

Authors:  Dick B S Brashier; Sushil Sharma
Journal:  J Pharmacol Pharmacother       Date:  2012-01

6.  Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum.

Authors:  Michael P Hengartner; Lukas Schulthess; Anders Sorensen; Adele Framer
Journal:  Ther Adv Psychopharmacol       Date:  2020-12-24

Review 7.  Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies.

Authors:  David Taylor; Anna Sparshatt; Seema Varma; Olubanke Olofinjana
Journal:  BMJ       Date:  2014-03-19

8.  Is There a Potential of Misuse for Venlafaxine and Bupropion?

Authors:  Fabrizio Schifano; Stefania Chiappini
Journal:  Front Pharmacol       Date:  2018-03-21       Impact factor: 5.810

Review 9.  Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.

Authors:  Fabrizio Schifano; Stefania Chiappini; John M Corkery; Amira Guirguis
Journal:  Brain Sci       Date:  2018-04-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.